NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year 
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal 
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025 
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
BETHLEHEM, Pa., May 10, 2017 -- OraSure Technologies, Inc. (NASDAQ:OSUR), announced that its 2017 Annual Meeting of Stockholders will again be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) on Tuesday, May 16, 2017.
In order to access the meeting, interested parties may go to www.virtualshareholdermeeting.com/OSUR2017 five (5) minutes prior to the start of the meeting to log in. Stockholders must enter the control number that was provided in the Notice Regarding the Availability of Proxy Materials in order to vote and ask questions that are germane to the business being discussed at the meeting.
A replay of the webcast will be available 24 hours after the meeting is concluded and will be archived on OraSure Technologies' website for seven days.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and distribution of point-of-care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its first-to-market, innovative products include rapid tests for the detection of antibodies to HIV and HCV on the OraQuick® platform, oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications, and oral fluid laboratory tests for detecting various drugs of abuse. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, commercial and industrial entities and consumers. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health.
Company contact: Ronald H. Spair Chief Financial Officer 610-882-1820 [email protected] www.orasure.com Shauna White Corporate Marketing Manager 484-353-1575 [email protected] www.orasure.com
